BRENTUXIMAB
UNII C67ORA155P

Substance Identification & Data

This profile provides standardized clinical and technical data for Brentuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C67ORA155P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 775303-41-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C67ORA155P

CAS Registry Number

775303-41-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRENTUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2007

National Cancer Institute reference terminology for clinical and research data.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brentuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BRENTUXIMAB

BRENTUXIMAB VEDOTIN BRENTUXIMAB [MI]

MOAB, CHIMERIC, SGN-30, TO CD30 ANTIGEN

MONOCLONAL ANTIBODY SGN-30

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD30 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL SGN-30 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL SGN-30 .KAPPA.-CHAIN, DIMER

SYS